These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34162077)

  • 21. Occurrence and environmental implications of pharmaceuticals in Chinese municipal sewage sludge.
    Chen Y; Yu G; Cao Q; Zhang H; Lin Q; Hong Y
    Chemosphere; 2013 Nov; 93(9):1765-72. PubMed ID: 23827484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence and removal of 17α-ethynylestradiol (EE2) in municipal wastewater treatment plants: Current status and challenges.
    Tang Z; Liu ZH; Wang H; Dang Z; Liu Y
    Chemosphere; 2021 May; 271():129551. PubMed ID: 33453480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent approaches and advanced wastewater treatment technologies for mitigating emerging microplastics contamination - A critical review.
    Krishnan RY; Manikandan S; Subbaiya R; Karmegam N; Kim W; Govarthanan M
    Sci Total Environ; 2023 Feb; 858(Pt 1):159681. PubMed ID: 36302412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.
    Jelic A; Gros M; Ginebreda A; Cespedes-Sánchez R; Ventura F; Petrovic M; Barcelo D
    Water Res; 2011 Jan; 45(3):1165-76. PubMed ID: 21167546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial and temporal occurrence of pharmaceuticals and illicit drugs in the aqueous environment and during wastewater treatment: new developments.
    Baker DR; Kasprzyk-Hordern B
    Sci Total Environ; 2013 Jun; 454-455():442-56. PubMed ID: 23563258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-antiretrovirals in river water from Gauteng, South Africa: Mixed messages of wastewater inflows as source.
    Horn S; Vogt T; Gerber E; Vogt B; Bouwman H; Pieters R
    Sci Total Environ; 2022 Feb; 806(Pt 2):150346. PubMed ID: 34601177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence and fate of perfluorinated acids in two wastewater treatment plants in Shanghai, China.
    Zhang C; Yan H; Li F; Zhou Q
    Environ Sci Pollut Res Int; 2015 Feb; 22(3):1804-11. PubMed ID: 23933955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes.
    Nguyen PY; Carvalho G; Reis MAM; Oehmen A
    Water Res; 2021 Jan; 188():116446. PubMed ID: 33038717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology.
    Kołecka K; Gajewska M; Stepnowski P; Caban M
    Sci Total Environ; 2019 Jan; 647():149-157. PubMed ID: 30077845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening priority indicator pollutants in full-scale wastewater treatment plants by non-target analysis.
    Qian Y; Wang X; Wu G; Wang L; Geng J; Yu N; Wei S
    J Hazard Mater; 2021 Jul; 414():125490. PubMed ID: 33676247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'An investigation into the occurrence and removal of pharmaceuticals in Colombian wastewater'.
    Botero-Coy AM; Martínez-Pachón D; Boix C; Rincón RJ; Castillo N; Arias-Marín LP; Manrique-Losada L; Torres-Palma R; Moncayo-Lasso A; Hernández F
    Sci Total Environ; 2018 Nov; 642():842-853. PubMed ID: 30045524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seasonal and spatial variations of PPCP occurrence, removal and mass loading in three wastewater treatment plants located in different urbanization areas in Xiamen, China.
    Sun Q; Li M; Ma C; Chen X; Xie X; Yu CP
    Environ Pollut; 2016 Jan; 208(Pt B):371-81. PubMed ID: 26552527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of occurrence, fate and removal of priority phthalate esters (PAEs) in wastewater and sewage sludge by advanced biological treatment, waste stabilization pond and constructed wetland.
    Nas B; Ateş H; Dolu T; Yel E; Argun ME; Koyuncu S; Kara M; Dinç S
    Chemosphere; 2022 May; 295():133864. PubMed ID: 35150704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
    Ulvi A; Aydın S; Aydın ME
    Environ Sci Pollut Res Int; 2022 Oct; 29(50):75609-75625. PubMed ID: 35655023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
    Kreuzinger N; Clara M; Strenn B; Kroiss H
    Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution, mass load and environmental impact of multiple-class pharmaceuticals in conventional and upgraded municipal wastewater treatment plants in East China.
    Yuan X; Qiang Z; Ben W; Zhu B; Qu J
    Environ Sci Process Impacts; 2015 Mar; 17(3):596-605. PubMed ID: 25614232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustainable treatment systems for removal of pharmaceutical residues and other priority persistent substances.
    Baresel C; Ek M; Ejhed H; Allard AS; Magnér J; Dahlgren L; Westling K; Wahlberg C; Fortkamp U; Söhr S; Harding M; Fång J; Karlsson J
    Water Sci Technol; 2019 Feb; 79(3):537-543. PubMed ID: 30924808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Removal of pharmaceuticals and personal care products (PPCPs) from wastewater: A review.
    Wang J; Wang S
    J Environ Manage; 2016 Nov; 182():620-640. PubMed ID: 27552641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal.
    Martín J; Camacho-Muñoz D; Santos JL; Aparicio I; Alonso E
    J Hazard Mater; 2012 Nov; 239-240():40-7. PubMed ID: 22608399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.